Reduce the Cost of Sepsis Management

Faster patient data for quicker treatment decisions and cost savings

The value of the T2Direct Diagnostics™ is clear: multiple hospitals have shown that making targeted treatment decisions faster leads to improved outcomes, better stewardship, and reduced cost of sepsis management. T2Direct Diagnostics has proven to:

  • Significantly reduce hospital and ICU lengths of stay
  • Reduce the use of antimicrobial drugs

For a patient with a positive T2 test result, hospitals are typically experiencing $20,000 in hospital savings.1 A rapid T2 negative result reduces the costs associated with antimicrobial drugs, while adding the benefit of CPT® reimbursement for non-admitted patients.

Contact T2 to request an economic assessment.


1. Wilson, N.M., Kenney, R.M., Tibbetts, R.J., et al. T2 Magnetic Resonance Improves the Timely Management of Candidemia. Poster Presentation IDWeek 2016
2. Estrada, S.J. Real World Value of T2Candida. Lee Memorial Hospital. Slide Presentation ASM 2016.